Papers matching “adjuvant chemotherapy response” 37
Not finding it? Sign in to also search OpenAlex live.
-
Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02)2026 The Breast article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Mark Opdam, N. Ultee, Jill J.J. Geenen, Annelot G.J. van Rossum, Ingrid A.M. Mandjes, Sara Balduzzi, +5 more
0citations -
The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database2022 Diseases of the Colon & Rectum article Medicine Colorectal Cancer Surgical Treatments Open access
Laura Melina Fernandez, Guilherme Pagin São Julião, Andrew G. Renehan, Geerard L. Beets, Ana Luísa Papoila, Bruna Borba Vailati, +7 more
94citations -
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer2024 npj Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Volker J. Möbus, Hans‐Joachim Lück, Ekkehart Ladda, Peter Klare, Knut Engels, Marcus Schmidt, +20 more
2citations -
MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study
Fleur M. Louis, Anna van der Voort, Mette S. van Ramshorst, Antonios Daletzakis, Ingrid A.M. Mandjes, Inge Kemper, +53 more
11citations -
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer2023 Journal of Clinical Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access
Nanda Horeweg, Remi A. Nout, Ina Maria Jurgenliemk-Schulz, Ludy C.H.W. Lutgens, Jan J. Jobsen, Marie A.D. Haverkort, +38 more
104citations -
Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents
Marit Martina Melssen, Caroline T. Fisher, Craig Lee Slingluff, Cornelis J.M. Melief
42citations -
Clinical relevance of CA125 in low-grade serous ovarian cancer: a retrospective multi-center JAGO/NOGGO study2026 International Journal of Gynecological Cancer article Medicine Ovarian cancer diagnosis and treatment Open access
Chiara Flethe, Mina Netkova-Heintzen, Magdalena Postl, L. Tascón Padrón, Christina Victoria Isabella Tauber, Elisa Sieghartsleitner, +7 more
0citations -
Update Breast Cancer 2021 Part 1 – Prevention and Early Stages2021 Geburtshilfe und Frauenheilkunde article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Elmar Stickeler, Bahriye Aktas, Annika Sophie Behrens, Erik Belleville, Nina Ditsch, Peter Andreas Fasching, +21 more
14citations -
Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET2023 Journal of Nuclear Medicine article Neuroscience Brain Tumor Detection and Classification Open access
Robin Gutsche, Carsten Lowis, K. Ziemons, Martin Köcher, Garry S. Ceccon, Cláudia Régio Brambilla, +5 more
30citations -
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, Hein Putter, Irıs D. Nagtegaal, +9 more
43citations -
Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)2024 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Philipp Meyer-Wilmes, Jens Huober, Michael Untch, Jens‐Uwe Blohmer, Wolfgang Janni, Carsten Denkert, +18 more
6citations -
The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer2020 Therapeutic Advances in Medical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Ulrike Anneliese Nitz, Oleg Gluz, Hans Heinrich Kreipe, Matthias Christgen, Sherko Küemmel, Frederick L. Baehner, +16 more
46citations -
SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT-ov78).
Benoît You, Nozomu Yanaihara, Gabriella Parma, Sylvie Chabaud, L. Del Carpio, Andrew R. Clamp, +10 more
2citations